IndietroExam 3 Study Guide: Infectious Disease, Host-Microbe Interactions, Biomedical Applications, Antimicrobial Drugs, Respiratory, Skin, and Eye Infections
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Principles of Infectious Disease
Categories of Pathogenic Organisms and Vectors
Pathogens include bacteria, viruses, fungi, protozoa, and helminths.
Vectors are living organisms (often arthropods like mosquitoes or ticks) that transmit pathogens between hosts.
Infectious Disease Vocabulary
Pathogenicity: The ability of a microbe to cause disease.
Virulence: The degree of pathogenicity within a group or species.
Reservoir: The natural habitat of a pathogen.
Carrier: An individual who harbors a pathogen without showing symptoms.
Koch’s Postulates
Set of criteria to establish a causative relationship between a microbe and a disease:
The microorganism must be found in all organisms suffering from the disease, but not in healthy organisms.
The microorganism must be isolated from a diseased organism and grown in pure culture.
The cultured microorganism should cause disease when introduced into a healthy organism.
The microorganism must be re-isolated from the inoculated, diseased experimental host and identified as being identical to the original specific causative agent.
Limitations: Some pathogens cannot be cultured, some diseases are caused by multiple organisms, and ethical issues may prevent experimentation.
Modes of Transmission
Direct transmission: Physical contact, droplets, vertical (mother to child).
Indirect transmission: Fomites, vectors, contaminated food/water.
Five Stages of Infection
Incubation period
Prodromal phase
Acute phase
Period of decline
Convalescent phase
Epidemiology
Definition: Study of the distribution and determinants of health-related states in populations.
Goals: Identify causes, patterns, and control of diseases.
Epidemiological triangle: Agent, host, environment.
Breaking the triangle: Remove one component to stop disease spread (e.g., vaccination, sanitation).
Conditions Necessary for Disease
Susceptible host
Pathogen with sufficient virulence
Proper environment for transmission
Measures of Frequency and Association
Incidence: Number of new cases in a population over a period.
Prevalence: Total number of cases at a given time.
Relative risk (RR) and odds ratio (OR) measure association between exposure and disease.
Descriptive vs. Analytical Epidemiological Studies
Descriptive: Characterize distribution of disease (who, where, when).
Analytical: Investigate causes and risk factors (how, why).
Healthcare-Associated Infections (HAIs)
Transmission: Direct contact, contaminated equipment, airborne.
Prevention: Hand hygiene, sterilization, isolation protocols.
Surveillance Programs
Purpose: Monitor and control disease spread.
Classifications: Passive, active, sentinel, syndromic.
Ethics: Protect privacy, informed consent.
Host-Microbe Interactions
Types of Host-Microbe Interactions
Mutualism: Both host and microbe benefit.
Commensalism: Microbe benefits, host unaffected.
Parasitism: Microbe benefits, host is harmed.
Opportunistic Pathogens
Cause disease in immunocompromised hosts or when introduced to unusual sites.
Tropism and Host Range
Tropism: Preference of a pathogen for a specific host tissue.
Host range: Spectrum of hosts a pathogen can infect.
Virulence and Mechanisms
Virulence: Degree of pathogenicity.
Mechanisms: Toxins, adhesion factors, immune evasion.
R Numbers, ID, and LD Values
R number (R0): Average number of secondary cases from one infected individual.
ID50: Infectious dose for 50% of population.
LD50: Lethal dose for 50% of population.
Endotoxins and Exotoxins
Endotoxins: Lipopolysaccharide (LPS) from Gram-negative bacteria; released on cell death.
Exotoxins: Proteins secreted by bacteria; diverse mechanisms (e.g., neurotoxins, enterotoxins).
Biosafety Levels (BSL)
BSL-1: Non-pathogenic microbes; minimal precautions.
BSL-2: Moderate risk; lab coats, gloves.
BSL-3: Aerosol transmission; controlled access, biosafety cabinets.
BSL-4: High risk, life-threatening; full-body suits, specialized facilities.
Biomedical Applications
Vaccine History and Types
History: Edward Jenner (smallpox), Louis Pasteur (rabies), Jonas Salk (polio).
Types: Live attenuated, inactivated, subunit, toxoid, conjugate, mRNA, viral vector.
Applications: Prevent infectious diseases, control outbreaks.
Immunologic Tests
Purpose: Detect antigens or antibodies.
Protocols: ELISA, agglutination, immunofluorescence.
Applications: Diagnosis, blood typing, monitoring immunity.
Genetic Manipulations
Genetic engineering: Creating recombinant plasmids and cells for research or therapy.
PCR and RT-PCR: Amplify DNA/RNA for detection and analysis.
CRISPR-Cas9: Genome editing tool for targeted modifications.
Gene therapy: Treating diseases by correcting defective genes.
Genome mapping and microarrays: Analyze gene expression and genetic variation.
Antimicrobial Drugs
Classifications and Relationships
Classified by target (cell wall, protein synthesis, nucleic acid synthesis, etc.) and spectrum (broad vs. narrow).
Key Definitions
Broad spectrum: Effective against many organisms.
Narrow spectrum: Effective against specific organisms.
-static vs. -cidal: Inhibit growth vs. kill microbes.
Therapeutic index: Ratio of toxic dose to therapeutic dose.
Selective toxicity: Drug harms pathogen, not host.
Major Antibiotic Classes
Class | Structure | Mechanism | Spectrum/Target | Examples | Side Effects |
|---|---|---|---|---|---|
Penicillins | Beta-lactam ring | Inhibit cell wall synthesis | Gram-positive, some Gram-negative | Penicillin G, amoxicillin | Allergy, GI upset |
Glycopeptides | Large peptide | Inhibit cell wall synthesis | Gram-positive | Vancomycin | Nephrotoxicity |
Quinolones | Quinoline core | Inhibit DNA gyrase | Broad | Ciprofloxacin | Tendon rupture |
Macrolides | Macrocyclic lactone | Inhibit protein synthesis | Gram-positive, some Gram-negative | Erythromycin | GI upset |
Polypeptides | Peptide chain | Disrupt cell membrane | Gram-negative | Polymyxin B | Neurotoxicity |
Antivirals, Antifungals, Antiprotozoals, Antihelminths
Antivirals: Inhibit viral entry, replication, or release (e.g., acyclovir, oseltamivir).
Antifungals: Target ergosterol or cell wall (e.g., amphotericin B, fluconazole).
Antiprotozoals: Inhibit nucleic acid or protein synthesis (e.g., metronidazole).
Antihelminths: Disrupt metabolism or neuromuscular function (e.g., mebendazole).
Assessing Antimicrobial Sensitivity
Kirby-Bauer test: Disk diffusion assay for susceptibility.
E-test: Gradient strip for MIC determination.
Broth dilution: Determines MIC and MBC (minimum bactericidal concentration).
Drug Resistance
Acquisition: Mutation, horizontal gene transfer.
Mechanisms: Enzyme inactivation, target modification, efflux pumps.
Prevention: Appropriate use, combination therapy, infection control.
Drug Development
Steps: Discovery, preclinical testing, clinical trials, approval.
Obstacles: Cost, resistance, toxicity, regulatory hurdles.
Respiratory System Infections
Structure and Function
Upper and lower respiratory tracts; functions in gas exchange and defense.
Normal Microbiota
Located in upper tract; includes Streptococcus, Staphylococcus, Corynebacterium.
Allergies vs. Infections
Allergies: Immune response to non-pathogenic antigens; symptoms include sneezing, itching; treated with antihistamines.
Infections: Caused by pathogens; symptoms include fever, pus; treated with antimicrobials.
Viral Respiratory Infections
Disease | Causative Agent | Transmission | Symptoms | Diagnosis | Prevention/Treatment |
|---|---|---|---|---|---|
Colds | Rhinoviruses | Droplets, contact | Sneezing, runny nose | Clinical | Supportive care |
Influenza | Influenza virus | Droplets | Fever, cough | Rapid antigen test | Vaccination, antivirals |
COVID-19 | SARS-CoV-2 | Droplets, aerosols | Fever, cough, loss of taste | PCR | Vaccination, supportive |
Hantavirus | Hantavirus | Rodent excreta | Fever, respiratory distress | Serology | Supportive |
Bacterial Respiratory Infections
Otitis media: Streptococcus pneumoniae, Haemophilus influenzae; ear pain, fever; diagnosed clinically; treated with antibiotics.
Streptococcal pharyngitis: Streptococcus pyogenes; sore throat, fever; rapid strep test; antibiotics.
Diphtheria: Corynebacterium diphtheriae; pseudomembrane, sore throat; culture; antitoxin, antibiotics.
Pertussis: Bordetella pertussis; whooping cough; PCR; antibiotics, vaccination.
Tuberculosis: Mycobacterium tuberculosis; chronic cough, weight loss; sputum test; multi-drug therapy.
Bacterial pneumonias: Streptococcus pneumoniae, Klebsiella pneumoniae; cough, fever; chest X-ray; antibiotics.
Fungal Respiratory Infections
Blastomycosis: Blastomyces dermatitidis; inhalation; fever, cough; culture; antifungals.
Coccidiomycosis: Coccidioides immitis; inhalation; chest pain; serology; antifungals.
Histoplasmosis: Histoplasma capsulatum; inhalation; flu-like; antigen test; antifungals.
Pneumocystis pneumonia: Pneumocystis jirovecii; immunocompromised; cough, hypoxia; microscopy; TMP-SMX.
Mucormycosis: Mucor spp.; inhalation; necrosis; biopsy; antifungals.
Aspergillosis: Aspergillus spp.; inhalation; hemoptysis; imaging; antifungals.
Skin and Eye Infections
Structure and Function of Skin
Skin: Epidermis, dermis, subcutaneous layers; barrier and immune functions.
Viral Skin Infections
Disease | Causative Agent | Transmission | Symptoms | Diagnosis | Prevention/Treatment |
|---|---|---|---|---|---|
Varicella-zoster | Varicella-zoster virus | Airborne, contact | Rash, fever | Clinical | Vaccine, antivirals |
Smallpox | Variola virus | Airborne | Pustular rash | Clinical | Vaccine (eradicated) |
Herpes simplex 1 | HSV-1 | Contact | Cold sores | Clinical, PCR | Antivirals |
Measles | Measles virus | Airborne | Rash, Koplik spots | Serology | Vaccine |
Rubella | Rubella virus | Airborne | Rash, fever | Serology | Vaccine |
HPVs (warts) | Human papillomavirus | Contact | Warts | Clinical | Cryotherapy, vaccine |
Bacterial Skin Infections
Acne: Cutibacterium acnes; blocked follicles; topical/oral antibiotics.
Staphylococcus aureus diseases: Impetigo, cellulitis, abscesses; contact; antibiotics.
Streptococcus pyogenes diseases: Erysipelas, necrotizing fasciitis; contact; antibiotics.
Pseudomonas aeruginosa diseases: Wound infections, especially burns; antibiotics.
Gangrene: Clostridium perfringens; trauma; debridement, antibiotics.
Cutaneous anthrax: Bacillus anthracis; spores; antibiotics.
Fungal Skin Infections
Mycoses: General term for fungal infections.
Candidiasis: Candida albicans; moist areas; antifungals.
Dermatophytic infections: Trichophyton, Microsporum; ringworm; topical/oral antifungals.
Parasitic Skin Infections
Leishmaniasis: Leishmania spp.; sandfly vector; cutaneous, mucocutaneous, visceral forms; antiprotozoals.
Eye Structure, Function, and Diseases
Structures: Cornea, conjunctiva, sclera, retina.
Functions: Vision, protection.
Diseases: Conjunctivitis, keratitis, endophthalmitis; caused by bacteria, viruses, fungi, or parasites.
Defenses: Tears (lysozyme), blinking, immune cells.
Additional info: Where details were not specified, standard textbook knowledge was used to fill in mechanisms, examples, and protocols.